A 20-year audit of retinoblastoma treatment outcomesKaan Gündüz, Mehmed Uğur Işık, Serdal Kenan Köse et al.|Eye|2020Cited by 38
Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: Risk factors and treatment resultsKaan Gündüz, Funda Seher Özalp Ateş, İbadulla Mirzayev et al.|European Journal of Ophthalmology|2021Cited by 11
Correction: A 20-year audit of retinoblastoma treatment outcomesKaan Gündüz, Mehmed Uğur Işık, Funda Seher Özalp Ateş et al.|Eye|2020Cited by 3